Nano-technology and nano-toxicology

Emerging Health Threats Journal

Volumn 5, Issue 1, 2012, Pages

  Maynard, Robert L ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Nano particle(s); Nano technology; Nano toxicology

Indexed keywords

IRIDIUM 192; OXYGEN RADICAL;

AEROSOL; ALZHEIMER DISEASE; ARTICLE; BETA RADIATION; CELL DAMAGE; FINANCIAL MANAGEMENT; GAMMA RADIATION; HEALTH HAZARD; HUMAN; NANOANALYSIS; NANOCHEMISTRY; NANOFILTER; NANOTECHNOLOGY; NANOTOXICOLOGY; NONHUMAN; PARTICLE SIZE; PHASE TRANSITION; RADIOACTIVITY; RETROGRADE NERVE FIBER TRANSPORT; RISK ASSESSMENT; RISK FACTOR;

EID: 84869779055     PISSN: None     EISSN: 17528550     Source Type: Journal    
DOI: 10.3402/ehtj.v5i0.17508     Document Type: Article

References (46)

1. Robinson KS. Red Mars. Harper Collins 1992; Green Mars. Harper Collins 1992; Blue Mars. Harper Collins 1996 (Voyager imprint).
2. McDevitt MR, Chattopadhyay D, Kappel BJ, Jagghi JS, Schiffman SR, Antczak C, et al. Tumor targeting with antibody-functionalized radiolabeled caron nanotubes. J Nucl Med. 2007;48:1180-9.
3. Longmire M, Choyke PL, Kobayashi H. Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicine. 2008;3:703-17.
4. Monteiro-Riviere Nancy A, Tran CL. Nanotoxicology, characterization, dosing and health effects. New York and London: Informa Healthcare; 2007.
5. Cassee FR, Mills NL, Newby DE. Cardiovascular effects of inhaled ultrafine and nano-sized particles. Hoboken, NJ: John Wiley and Sons Inc.; 2011.
6. Brown LM, Collings N, Harrison RM, Maynard AD, Maynard RL. Ultrafine particles in the atmosphere. London: Imperial College Press; 2003. (first published by The Royal Society, 2000)
7. International Council of Nanotechnology. Towards predicting nano-biointeractions, Number 4; 2008 May 1, Houston, USA: International Council on Nanotechnology.
8. The Royal Society. Nanoscience and nanotechnologies: opportunities and uncertainties. London: The Royal Society; 2004.
9. Borm PJA, Robbins D, Haubold S, Kuhlbusch T, Fissan H, Donaldson K, et al. The potential risks of nanomaterials: a review carried out for ECETOC. Part Fibre Toxicol. 2006; 3:11. Available from: http://www.particleandfibretoxicology. com/content/3/1/11.
10. Maynard AD. Nanotechnology: the next big thing or much ado about nothing? Ann Occup Hyg. 2007;51:1-12.
11. Muller J, Huauz F, Lison D. Respiratory toxicity of carbon nanotubes: how worried should we be? Carbon. 2006;44: 1048-56.
12. Oberdörster G, Oberdörster E, Oberdörster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect. 2005;113:823-39.
13. 2 rods and dots in rates: toxicity is not dependent upon particle size and surface area. Toxicol Sci. 2006;91:227-36.
14. Seaton A, MacNee W, Donaldson K, Godden D. Particulate air pollution and acute health effects. Lancet. 1995;354:176-8.
15. Peters A, Doring A, Wichmann HE, Koenig W. Increased plasma viscosity during an air pollution episode: a link with mortality. Lancet. 349:1582-7.
16. Delfino RJ, Sioutas C, Malik S. Potential role of ultrafine particles in associations between airborne particle mass and cardiovascular health. Environ Health Perspect. 2005;113: 934-46.
17. Geys J, Nemmar A, Verbeken E, Smolders E, Ratoi M, Hoylaerts MF, et al. Acute toxicity and prothrombotic effects of Quantum Dots: impact of surface charge. Environ Health Perspect. 2008;116:1607-13.
18. Oberdörster G, Ferin J, Lehnert BE. Correlation between particle size, in vivo particle persistence and lung injury. Environ Health Perspect. 1994;102:173-9.
19. Ferin J, Oberdörster G, Soderholm SC, Gelein R. Pulmonarty tissue access of ultrafine particles. J Aerosol Med. 1991;4:57-68.
20. Oberdörster G, Ferin J, Gelein R, Soderholm SC, Finkelstein J. Role of the alveolar macrophage in lung injury: studies with ultrafine particles. Environ Health Perspect. 1992;97:193-9.
21. Ferin J, Oberdöster G, Penney DP. Pulmonary retention of ultrafine and fine particles in rats. Am J Respir Cell Mol Biol. 1992;6:535-42.
22. Brown DM, Stone V, Findlay P, MacNee W, Donaldson K. Increased inflammation and intracellular calcium caused by ultrafine carbon black is independent of transition metals or other soluble components. Occup Environ Med. 2000;57: 685-91.
23. Poland CA, Duffin R, Kinloch I, Maynard A, Wallace WAH, Seaton A, et al. Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat Nanotechnol. 2008;3:423-8.
24. Takagi A, Hirose A, Nishimura T, Fukomori N, Ogata A, Ohashi N, et al. Induction of mesothelioma in p53-/- mouse by intraperitoneal application of multi-wall carbon nanotube. J Toxicol Sci. 2008;33:105-16.
25. Mercer RR, Hubbs AF, Scabilloni JF, Wang L, Battelli LA, Schwegler-Berry D, et al. Distribution and persistence of pleural penetrations by multi-walled carbon nanotubes. Part Fibre Toxicol. 2010;7:28. Available from: http://www.particleandfibretoxicology.con/content/7/1/28.
26. Oberdörster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, et al. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol. 2005;2:8. Available from: http://www.particleandfibretoxicology.com/content/2/1/8.
27. Fubini B, Ghiazza M, Fenoglio I. Physico-chemical features of engineered nanoparticles relevant to their toxicity. Nanotoxicology. 2010;4:347-63.
28. Van Gulijk C, Marijinissen JCM, Makkee M, Moulijn JA, Schmidt-Ott A. Measuring diesel soot with a scanning mobility particles sizer and an electrical low-pressure impactor: performance assessment with a model for fractal agglomerates. Aerosol Sci. 2004;35:633-55.
29. Bihari P, Vippola M, Schultes S, Praetner M, Khandoga AG, Reichel CA et al. Optimized dispersion of nanoparticles for biological in viro and in vivo studies. Part Fibre Toxicol. 2008; 5:14. Available from: http://www.particleandfibretoxicology.com/content/5/1/14.
30. Kreyling WG, Semmler M, Erbe F, Mayer P, Takenaka S, Schulz H. Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low. J Toxicol Environ Health. 2002;65:1513-30.
31. Choi HS, Ashitate Y, Lee JH, Kim SH, Matsui A, Insin N, et al. Rapid translocation of nanoparticles from the lung airspaces to the body. Nat Biotechnol. 2010;28:1300-4.
32. Geiser M, Rothen-Rutishauser B, Kapp N, Schurch S, Kreyling W, Schultz H, et al. Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells. Environ Health Perspect. 2005;113:1555-60.
33. Geiser M, Casaulta M, Kupferschmid B, Schulz H, Semmler-Behnke M, Kreyling W. The role of macrophages in the clearance of inhaled ultrafine titanium dioxide particles. Am J Respir Cell Biol Med. 2008;38:371-6.
34. Kendall M, Tetley TD, Wigzell E, Hutton B, Nieuwenhuijsen M, Luckham P. Lung lining liquid modifies PM2.5 in favour of particle aggregation: a protective mechanism. Am J Physiol Lung Cell Mol Physiol. 2002;282:L109-14.
35. Stebounova LV, Guio E, Grassian VH. Silver nanoparticles in simulated biological media: a study of aggregation, sedimentation and dissolution. J Nanopart Res. 2011;13:233-44.
36. Geiser M, Schürch S, Gehr P. Influence of surface chemistry and topography of particles on their immersion into the lung's surface-lining layer. J Appl Physiol. 2003;94:1793-801.
37. Harishchandra RK, Saleem M, Galla H-J. Nanoparticle interaction with model lung surfactant monolayers. J R Soc Interface. 2010;7:S15-26.
38. Semmler-Behnke M, Takenaka S, Fertsch S, Wenk A, Seitz J, Mayer P, et al. Efficient elimination of inhaled nanoparticles from the alveolar region: evidence for interstitial uptake and subsequent reentrainment onto airways epithelium. Environ Health Perspect. 2007;115:728-33.
39. Maynard RL, Tetley T, Donaldson K. Type 1 epithelial cells: a new compartment involved in the slow phase of particle clearance from alveoli. J Nanotoxicol. 2012 (in press).
40. Elder A, Gelein R, Silva V, Feikert T, Opanashuk L, Carter J, et al. Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ Health Perspect. 2006;114:1172-8.
41. Xia T, Korge P, Weiss JN, Li N, Venkatesen MI, Sioutas C, et al. Quinones and aromatic chemical compounds in particulate matter induce mitochondrial dysfunction: implications for ultrafine particle toxicology. Environ Health Perspect. 2004;112:1347-58.
42. Geiser M, Kreyling WG. Deposition and biokinetics of inhaled nanoparticles. Part Fibre Toxicol. 2010;7:2. Available from: http://www.particleandfibretoxicology.com/content/7/1/2.
43. Morrow P. Dust overloading of the lungs: update and appraisal. Toxicol Appl Pharmacol. 1992;113:1-12.
44. Kuschner WG, Wong H, D'Alessandro A, Quinlan P, Blanc PD. Human pulmonary responses to experimental inhalation of high concentration fine and ultrafine magnesium oxide particles. Environ Health Perspect. 1997;105:1234-7.
45. Kunzli N, Jerrett M, Mack Wendy J, Beckerman B, LeBree L, Gilliland F, et al. Ambient air pollution and atherosclerosis in Los Angeles. Environ Health Perspect. 2005;113:201-6.
46. Aitken RJ, Creely KS, Tran CL. Nanoparticles: an occupational hygiene review. Norwich: HMSO/HSE Books; 2004.